Thursday, February 21, 2013

Journals on the Web

Drug News & Perspectives






  
Drug News Perspect 2008, 21(10): 533
ISSN 0214-0934
Copyright 2008 Prous Science
CCC: 0214-0934
 





LOOKING AHEAD
Future studies should demonstrate that the benefits of therapeutic use of cannabinoid ligands for bone diseases outweigh the risks.
Role of Cannabinoid Receptors in Bone Disorders: Alternatives for Treatment
by Aymen I. Idris


Summary
A number of recent preclinical studies have demonstrated the potential role of cannabinoids and their receptors in bone metabolism. Pharmacological and genetic modulation of cannabinoid receptors indicate that cannabinoid ligands may provide attractive and novel agents for the treatment of bone diseases. This article reviews the role of cannabinoid receptors in regulating bone mass, bone loss and bone cell function in health and disease. The article also provides support to the notion that cannabinoid receptor ligands show a great promise in the treatment of bone diseases associated with accelerated osteoclastic bone resorption including osteoporosis, rheumatoid arthritis and bone metastasis.Copyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved.

No comments:

Post a Comment